![ECCO 2018 - European Crohns and Colitis Organisation 13th Annual Congress, Messe Wien, Vienna, Wien, Austria | eMedEvents ECCO 2018 - European Crohns and Colitis Organisation 13th Annual Congress, Messe Wien, Vienna, Wien, Austria | eMedEvents](https://d3p2qewzsoh75c.cloudfront.net/uploads/conferences/logo/100/7358ee7657398cee53199aee8d74e103.jpg)
ECCO 2018 - European Crohns and Colitis Organisation 13th Annual Congress, Messe Wien, Vienna, Wien, Austria | eMedEvents
Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Pati
![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/30c83fd2-8e84-4190-a688-d0a9d502d46f/gr1.jpg)